Image

Blood Flow Restriction (BFR) Training on the Ulnar Collateral Ligament (UCL)

Blood Flow Restriction (BFR) Training on the Ulnar Collateral Ligament (UCL)

Recruiting
18-50 years
All
Phase N/A

Powered by AI

Overview

The goal of this clinical trial is to identify any differences in elbow ulnar collateral ligament (UCL) relative thickness and joint space laxity in the dominant arm following an 8-week course of low intensity resistance exercises with blood flow restriction (BFR) exercises in healthy volunteers. The main questions it aims to answer are:

  1. Do BFR exercises contribute to a change in the relative ligament thickness of the UCL, and changes in the ulnohumeral joint space?
  2. Are there changes in arm strength following the 8-week strengthening protocol with/without BFR?

Participants will:

  • Complete two BFR sessions a week for a total of eight weeks.
  • Complete an exercise session with both arms (dominant arm will receive BFR) at each study visit.
  • Have sonographs taken of the UCL at the first and last study visit.
  • Complete strength assessments at the first and last study visit.

Eligibility

Inclusion Criteria:

  • Healthy volunteer
  • Agree to complete all exercise sessions and program in its entirety
  • Between the ages of 18-50 years old

Exclusion Criteria:

  • Current or recent injury of the hand, elbow, or shoulder
  • Outside of the ages of 18-50 years old
  • Vascular compromise or previous vascular surgery
  • History of DVT
  • Current participation in other BFR research study
  • Currently participating in a structured strength training program
  • Any musculoskeletal conditions resulting in inability to exercise
  • Participants may not be collegiate/professional baseball/softball players
  • Vulnerable populations

Study details
    Healthy
    Healthy Male and Female Subjects
    Healthy Volunteers

NCT06664827

The Methodist Hospital Research Institute

27 January 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.